Search

everythinglearnresearchcommunity

for

Search:↓

Low-dose dutasteride effectively and safely promotes hair growth in men.

Potential androgen excess signs vary by demographics and health, needing inclusive evaluation.

Dutasteride does not impair mental function in elderly men with enlarged prostate.

KSR1 is crucial for certain skin tumor formation and could be a cancer therapy target.

Some dibenzo compounds might help treat cancer with fewer side effects.

Men taking dutasteride may have a higher risk of age-related macular degeneration.

Using cosmetics made elderly people feel more comfortable and attractive.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

The document listed medical job ads and guidelines for breast cancer screening.

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

Araliadiol protects skin cells from damage by boosting antioxidant defenses.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

Dutasteride shows promise as a potential treatment for Parkinson's disease.

Presurgical models can effectively and affordably screen cancer prevention agents.

Dutasteride 0.5mg is more effective than finasteride 1mg for treating male pattern baldness.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

ADF8 and ADF11 help root hairs grow by responding to hormones and environmental signals.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

Men with androgenetic alopecia do not have elevated DHEA-S levels.

Polydopamine is a safe, effective, and permanent hair dye that turns gray hair black in one hour.

The research created new azasteroids and pseudoazulenyl nitrones, which could be useful in medicine.

Orphan drug benefit scores in Germany are influenced by phase III data and lack of alternatives, but not linked to price or discounts.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

Metabolite 7 is a strong inhibitor for Alzheimer's disease management.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Fexofenadine may help treat a difficult type of hair loss.

A new treatment for hair loss shows promise with fewer side effects.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.